As of 2026-04-03, 大参林's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, below the industry average by 6.5 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 大参林's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
大参林's Mention Rate is 0.00%, lower than 0.6% of competitors
大参林's First Mention is 0.00%, lower than 0.9% of competitors
大参林's Preferred Rate is 0.00%, lower than 100.0% of competitors
大参林's Positive Rate is 0.00%, lower than 8.9% of competitors
大参林's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 恒恒瑞医药 | 70.77% | 18.46% | 36.84% | 67.69% | 6.15% | View Details |
| 百百济神州 | 66.15% | 12.31% | 0% | 58.46% | 1.54% | View Details |
| 礼礼来 | 58.46% | 41.54% | 47.37% | 55.38% | 0% | View Details |
| 中中国生物制药 | 40% | 0% | 0% | 33.85% | 0% | View Details |
| 罗罗氏 | 38.46% | 1.54% | 5.26% | 35.38% | 0% | View Details |
| 石石药集团 | 38.46% | 0% | 0% | 32.31% | 1.54% | View Details |
| 大大参林 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
